Related Experiment Video
Updated: May 21, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Acute liver failure in children: 20-year experience
Zeren Bariş1, Inci Nur Saltik Temızel, Nuray Uslu
1Gazi University Hospital, Pediatric Gastroenterology, Ankara, Turkey. zeren_baris@yahoo.com
Summary
Metabolic and infectious causes led to most pediatric acute liver failure cases. High bilirubin and INR levels predicted mortality, while encephalopathy was not always present in children.
Area of Science:
- Pediatric Hepatology
- Pediatric Gastroenterology
- Critical Care Medicine
Background:
- Acute liver failure (ALF) in children presents unique challenges in diagnosis and management.
- Understanding the specific etiologies and risk factors is crucial for improving outcomes in pediatric ALF.
Purpose of the Study:
- To investigate the causes, demographics, clinical presentation, outcomes, and prognostic factors of pediatric ALF.
- To identify key indicators for predicting mortality in children with acute liver failure.
Main Methods:
- Retrospective case study of 74 pediatric patients diagnosed with acute liver failure.
- Data collected on etiology, clinical status, treatment, and outcomes over a 20-year period.
Main Results:
- Metabolic (35.1%) and infectious (28.4%) causes were the most common etiologies of ALF.
- Wilson's disease and hepatitis A were the leading metabolic and infectious agents, respectively.
- Mortality rate was 66.2%, with elevated total bilirubin, INR, and prothrombin time as significant predictors of death.
Conclusions:
- Metabolic and infectious diseases are primary drivers of pediatric ALF.
- Clinical encephalopathy may be absent in children with ALF, necessitating reliance on other clinical indicators.
- Prognostic factors like bilirubin and INR levels are vital for risk stratification in pediatric ALF.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...